Table 3

Clinical manifestations of patients with CMV anterior uveitis included number of antiglaucoma drugs and frequency of steroid eye drops in a day before and after topical 2% ganciclovir therapy

Patient no.Clinical before topical
2% ganciclovir
Clinical after topical
2% ganciclovir 12 months
Status of topical ganciclovir at 12 monthsNo. of recurrentTrabeculectomy with mitomycin C
Visual
acuity
CellKPsIOPGSVisual acuityCellKPsIOPGS
120/251++173420/2501720Off1
220/320.5+304420/2001611Once a day2
320/200.5+3221020/2001200Off0
420/601+284220/2501110Once a day0
520/400.5+134420/2501002Off
(at 6 months)
19th month
620/320.5+403620/200+1300Three times a day1
720/250+142420/200800Three times a day1
8HM4+3361620/2000.51624Once a day0
920/1000.5+444420/500600Off02nd month
10FC20.5+1514HM0111Off0
11FC10+1504FC1’01724Once a day (6 months)1
  • G, the number of antiglaucoma drugs.

  • S, the frequency of steroid drops per day.

  • CMV, cytomegalovirus; FC, finger count; HM, hand motion; IOP, intraocular pressure; KP, keratic precipitate.